The Ikerlan-IK4 and Gaiker-IK4 Technological Center have patented a device which is capable of the rapid and effective diagnosis of infectious diseases caused by various bacteria.
Roche’s XELOX (Xeloda(R) plus oxaliplatin) is an effective alternative to the current standard treatment, FOLFOX-4 (infused 5-FU/leucovorin plus oxaliplatin), for advanced (metastatic) colorectal cancer.
Scientists at the University of Liverpool have found how two molecules fight in the blood to control the spread of cancer cells.
A new study finds that obesity increases the risk of death from prostate cancer, even though it does not increase the overall risk a man will be diagnosed with the disease. The study reveals that higher body mass index (BMI) and weight gain in adulthood correlated strongly with increased risk of death from prostate cancer.
Telephone outreach can dramatically increase the incidence of screening for colorectal cancer (CRC) in an urban minority population, according to a new study published in the December 2006 issue of American Journal of Public Health.
Regular use of cholesterol-lowering drugs called statins is not associated with a reduced risk of colorectal cancer, according to a population-based case-control study.
Early colon cancer or colorectal cancer diagnosis was made possible by changes in Medicare reimbursement policy few years back. The study was published by Yale School of Medicine researchers in the December issue of Journal of the American Medical Association (JAMA). The study was funded by a Beeson Career Development Award to Gross, and by the Claude D. Pepper Older Americans Independence Center at Yale.
A study reveals that differences in utilization of screening tests and surgical treatment may contribute to poorer colorectal cancer survival rates in African-Americans.
Since Medicare raised the amount it will reimburse for colon cancer screening in 1998, there has been an increase in use of colonoscopies by Medicare beneficiaries, and a rise in the proportion of patients being diagnosed with colon cancer at an early stage, according to a study in the Dec. 20 issue of JAMA.
The female hormone estrogen may hold important clues for scientists working on new therapies for colon cancer, a study by Dana-Farber Cancer Institute researchers suggests.